<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA</journal-id><journal-id journal-id-type="iso-abbrev">JAMA</journal-id><journal-id journal-id-type="pmc-domain-id">3211</journal-id><journal-id journal-id-type="pmc-domain">jamasd</journal-id><journal-title-group><journal-title>JAMA</journal-title></journal-title-group><issn pub-type="ppub">0098-7484</issn><issn pub-type="epub">1538-3598</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>JAMA Network</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11840682</article-id><article-id pub-id-type="pmcid-ver">PMC11840682.1</article-id><article-id pub-id-type="pmcaid">11840682</article-id><article-id pub-id-type="pmcaiid">11840682</article-id><article-id pub-id-type="pmid">39969893</article-id><article-id pub-id-type="doi">10.1001/jama.2024.27976</article-id><article-id pub-id-type="publisher-id">joi240161</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="domain" specific-use="print"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-first"><subject>Online First</subject></subj-group></article-categories><title-group><article-title>Emergency Clinician Buprenorphine Initiation, Subsequent Prescriptions, and Continuous Prescriptions</article-title><alt-title alt-title-type="headline">Emergency Clinician Buprenorphine Initiation and Prescriptions</alt-title><alt-title alt-title-type="running-head">Emergency Clinician Buprenorphine Initiation and Prescriptions</alt-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Dekker</surname><given-names initials="AM">Annette M.</given-names></name><degrees>MD</degrees><degrees>MS</degrees><xref rid="joi240161aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schriger</surname><given-names initials="DL">David L.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><xref rid="joi240161aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="joi240161aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Herring</surname><given-names initials="AA">Andrew A.</given-names></name><degrees>MD</degrees><xref rid="joi240161aff3" ref-type="aff">
<sup>3</sup>
</xref><xref rid="joi240161aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Samuels</surname><given-names initials="EA">Elizabeth A.</given-names></name><degrees>MD</degrees><degrees>MPH</degrees><degrees>MHS</degrees><xref rid="joi240161aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="joi240161aff1"><label>1</label>Department of Emergency Medicine, David Geffen School of Medicine, University of California, Los Angeles</aff><aff id="joi240161aff2"><label>2</label>Associate Editor, <italic toggle="yes">JAMA</italic></aff><aff id="joi240161aff3"><label>3</label>Department of Emergency Medicine, Highland General Hospital&#8211;Alameda Health System, Oakland, California</aff><aff id="joi240161aff4"><label>4</label>Bridge Center, Public Health Institute, Oakland, California</aff><author-notes><title>Article Information</title><corresp id="joi240161cor1"><bold>Corresponding Author:</bold> Annette M. Dekker, MD, MS, Department of Emergency Medicine, David Geffen School of Medicine, University of California, Los Angeles, 1100 Glendon Ave, Ste 1200, Los Angeles, CA 90024 (<email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="adekker@mednet.ucla.edu">adekker@mednet.ucla.edu</email>).</corresp><p><bold>Accepted for Publication:</bold> December 15, 2024.</p><p content-type="published-online"><bold>Published Online:</bold> February 19, 2025. doi:<uri content-type="doi">10.1001/jama.2024.27976</uri></p><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Dekker and Schriger had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic toggle="yes">Concept and design</italic>: Dekker, Schriger, Herring.</p><p><italic toggle="yes">Acquisition, analysis, or interpretation of data</italic>: All authors.</p><p><italic toggle="yes">Drafting of the manuscript</italic>: All authors.</p><p><italic toggle="yes">Critical review of the manuscript for important intellectual content</italic>: All authors.</p><p><italic toggle="yes">Statistical analysis</italic>: Dekker, Schriger.</p><p><italic toggle="yes">Obtained funding</italic>: Schriger.</p><p><italic toggle="yes">Administrative, technical, or material support</italic>: All authors.</p><p><italic toggle="yes">Supervision</italic>: Schriger, Samuels.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Samuels reported providing evaluation consultation for Bridge. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> Dr Schriger&#8217;s time was supported in part by an unrestricted grant by the Korein Foundation. Dr Herring was partially supported by the National Institute on Drug Abuse/National Institutes of Health, the Alameda Health System, and the Public Health Institute. Dr Samuels was partially supported by the Centers for Disease Control and Prevention (R01CE003632).</p><p><bold>Role of the Funder/Sponsor:</bold> The supporters had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.</p><p><bold>Disclaimer:</bold> Dr Schriger is an Associate Editor at <italic toggle="yes">JAMA</italic> but was not involved in the editorial review of or decision to publish this article.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-JOI240161-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p><bold>Additional Contributions:</bold> We acknowledge Siddhartha Shendrikar, California Institute of Technology, and Omar Velazquez, MD, MPH, David Geffen School of Medicine, University of California, Los Angeles, for their contributions to computer programming in preliminary versions of the analysis. We also acknowledge the California Department of Justice Research Services for assistance in acquiring the deidentified CURES dataset used in this study. None of the aforementioned individuals or institutions received compensation for these contributions.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-02-19T10:00"><day>19</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><day>8</day><month>4</month><year>2025</year></pub-date><volume>333</volume><issue>14</issue><issue-id pub-id-type="pmc-issue-id">482599</issue-id><fpage>1232</fpage><lpage>1241</lpage><history><date date-type="received"><day>30</day><month>6</month><year>2024</year></date><date date-type="accepted"><day>15</day><month>12</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>08</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-04-10 00:25:13.760"><day>10</day><month>04</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright 2025 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies.</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jama-e2427976.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf-version" xlink:href="jama-e2427976.pdf">jama-e2427976.pdf</self-uri><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.27976"/><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="commentary" xml:lang="en" journal-id="JAMA" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="39969859"><article-title>State Investment in Emergency Department Buprenorphine Pays Off.</article-title><date><day>19</day><month>2</month><year>2025</year></date><source>JAMA</source><pub-id pub-id-type="doi">10.1001/jama.2025.0609</pub-id><pub-id pub-id-type="pmid">39969859</pub-id></related-article><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-joi240161-1"><title>Question</title><p>How did California emergency clinician buprenorphine initiation and subsequent prescriptions change from 2017 to 2022?</p></sec><sec id="ab-joi240161-2"><title>Findings</title><p>In this retrospective observational study, 345&#8201;024 patients filled 3.8 million buprenorphine prescriptions in California. Emergency clinicians increased from 2% to 16% of buprenorphine prescribers and their buprenorphine initiation increased from 0.1% to 5% of initiations. The ratio of initiation prescriptions to second prescriptions within 40 days was 2.8. The ratio of initiation prescriptions to 180 days or more of continuous prescriptions within 1 year was 9.1.</p></sec><sec id="ab-joi240161-3"><title>Meaning</title><p>From 2017 to 2022, California emergency clinicians increasingly adopted buprenorphine prescribing for opioid use disorder, with approximately 1 in 3 patients going on to receive a second prescription and approximately 1 in 9 patients going on to receive continuous prescriptions.</p></sec></abstract><abstract><sec id="ab-joi240161-4"><title>Importance</title><p>Rates of opioid use disorder (OUD) and associated mortality in the US remain high. Treatment of OUD with buprenorphine reduces morbidity and mortality. There have been national efforts to expand buprenorphine initiation to the emergency department (ED), where many patients with low treatment access seek medical care. Adoption and trends of emergency clinician buprenorphine prescribing are unknown.</p></sec><sec id="ab-joi240161-5"><title>Objective</title><p>To describe emergency clinician buprenorphine initiation for OUD, subsequent prescriptions, and changes over time in California.</p></sec><sec id="ab-joi240161-6"><title>Design, Setting, and Participants</title><p>Observational retrospective study of buprenorphine prescriptions in the California Controlled Substance Utilization Review and Evaluation System (CURES) database from January 1, 2017, to December 31, 2022. Any patient aged 18 to 79 years with a California zip code who filled a buprenorphine prescription in CURES and their California prescribers were eligible for inclusion.</p></sec><sec id="ab-joi240161-7"><title>Exposure</title><p>Buprenorphine prescription by an emergency clinician.</p></sec><sec id="ab-joi240161-8"><title>Main Outcomes and Measures</title><p>Outcomes included (1) the number of patients prescribed buprenorphine; (2) the number of clinicians prescribing buprenorphine; (3) the number and characteristics of buprenorphine prescriptions; (4) the percentage of emergency clinician buprenorphine initiation prescriptions with subsequent linkage to a second prescription and continuous prescriptions, also reported as a continuation ratio; and (5) days and number of initiation prescriptions prior to continuous prescriptions.</p></sec><sec id="ab-joi240161-9"><title>Results</title><p>In this retrospective observational study, 345&#8201;024 patients received 3.8 million buprenorphine prescriptions from 21&#8201;099 clinicians in California from 2017 to 2022. The mean age of patients at the time of first buprenorphine prescription was 37 years; 8187 (67%) were male. Emergency clinicians increased from 2% (n&#8201;=&#8201;78) to 16% (n&#8201;=&#8201;1789) of buprenorphine prescribers in 2017 and 2022, respectively (<italic toggle="yes">P</italic>&#8201;&lt;&#8201;.001). Buprenorphine initiation prescriptions by emergency clinicians increased from 0.1% (n&#8201;=&#8201;53) to 5% (n&#8201;=&#8201;4493) of all initiation prescriptions in 2017 and 2022, respectively (<italic toggle="yes">P</italic>&#8201;=&#8201;.001). The continuation ratio for patients to receive a second prescription within 40 days of an ED initiation was 2.8 (10&#8201;823/3916). The continuation ratio for patients to start 180 days or more of continuous prescriptions within 40 days of ED buprenorphine initiation was 18.3 (10&#8201;823/593) and 9.1 within 1 year (5989/655 [2017-2021 data]).</p></sec><sec id="ab-joi240161-10"><title>Conclusions and Relevance</title><p>These findings suggest increasing prescription of buprenorphine for OUD by California emergency clinicians from 2017 to 2022, with approximately 1 in 9 patients going on to receive continuous buprenorphine prescriptions within 1 year.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This observational study uses retrospective data to characterize patterns of emergency clinician buprenorphine initiation for opioid use disorder, subsequent prescription continuation, and changes over time in California.</p></abstract><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>